Skip to main content
Clinical Trials/NL-OMON28586
NL-OMON28586
Completed
Not Applicable

Distress and quality of life of patients treated with autologous stem cell transplantation following high-dose chemotherapy: outcome of stepped care.

Inholland University, Research Group Mental Health Nursing, Amsterdam, the NetherlandsVU University Medical Center, Amsterdam, the Netherlands0 sites128 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
hematological malignancy
Sponsor
Inholland University, Research Group Mental Health Nursing, Amsterdam, the NetherlandsVU University Medical Center, Amsterdam, the Netherlands
Enrollment
128
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Inholland University, Research Group Mental Health Nursing, Amsterdam, the NetherlandsVU University Medical Center, Amsterdam, the Netherlands

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with hematological malignancy (multiple myeloma, (relapsed) (non\-)Hodgkin lymphoma, acute myeloid leukemia, or acute lymphoid leukemia) treated with autologous stem cell transplantation following high\-dose chemotherapy;
  • 2\. Life expectation \> 3 months.

Exclusion Criteria

  • 1\. Age \< 18 or \> 65 years (65 is included);
  • 2\. Insufficient command of the Dutch language to complete questionnaires; or, if so: no support by family or professional interpreters;

Outcomes

Primary Outcomes

Not specified

Similar Trials